Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia

NCT00017342 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: bryostatin 1
DRUG: cytarabine

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]